These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC. J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [Abstract] [Full Text] [Related]
3. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis]. Schröder S, Baumann-Schröder U, Hazim W, Haase W, Mautner VF. Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799 [Abstract] [Full Text] [Related]
4. Optic radiation involvement in optic pathway gliomas in neurofibromatosis. Liu GT, Brodsky MC, Phillips PC, Belasco J, Janss A, Golden JC, Bilaniuk LL, Burson GT, Duhaime AC, Sutton LN. Am J Ophthalmol; 2004 Mar; 137(3):407-14. PubMed ID: 15013861 [Abstract] [Full Text] [Related]
5. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1. de Blank PM, Berman JI, Liu GT, Roberts TP, Fisher MJ. Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320 [Abstract] [Full Text] [Related]
6. Optic pathway glioma of childhood. Rasool N, Odel JG, Kazim M. Curr Opin Ophthalmol; 2017 May; 28(3):289-295. PubMed ID: 28257299 [Abstract] [Full Text] [Related]
8. Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas. Kelly JP, Weiss AH. J AAPOS; 2006 Aug; 10(4):298-306. PubMed ID: 16935227 [Abstract] [Full Text] [Related]
13. Orbital optic nerve gliomas in children with neurofibromatosis type 1. Zeid JL, Charrow J, Sandu M, Goldman S, Listernick R. J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147 [Abstract] [Full Text] [Related]
14. Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I. Vagge A, Camicione P, Pellegrini M, Gatti G, Capris P, Severino M, Di Maita M, Panarello S, Traverso CE. Eur J Ophthalmol; 2021 Mar; 31(2):698-703. PubMed ID: 32066268 [Abstract] [Full Text] [Related]
15. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ. Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105 [Abstract] [Full Text] [Related]
16. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE, Nuding MA. Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [Abstract] [Full Text] [Related]
17. The role of surgery in optic pathway/hypothalamic gliomas in children. Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C. J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145 [Abstract] [Full Text] [Related]
18. Visual loss in childhood. Liu GT. Surv Ophthalmol; 2001 Jan; 46(1):35-42. PubMed ID: 11525788 [Abstract] [Full Text] [Related]
19. Visual electrophysiology in children with tumours affecting the visual pathway. Case reports. Brecelj J, Stirn-Kranjc B, Skrbec M. Doc Ophthalmol; 2000 Sep; 101(2):125-54. PubMed ID: 11200546 [Abstract] [Full Text] [Related]
20. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR. Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226 [Abstract] [Full Text] [Related] Page: [Next] [New Search]